Our data demonstrate that as a result of IFNγ-R1 stabilization, STUB1 loss leads to enhanced IFNγ response as well as to strong sensitization to cytotoxic T cell-mediated tumor cell killing in vitro. The gene discussed is IFNGR1; the disease is neoplasm.